Literature DB >> 26219586

Assessment of D-methionine protecting cisplatin-induced otolith toxicity by vestibular-evoked myogenic potential tests, ATPase activities and oxidative state in guinea pigs.

Wu-Chia Lo1, Chih-Ming Chang2, Li-Jen Liao2, Chi-Te Wang2, Yi-Ho Young3, Yih-Leong Chang4, Po-Wen Cheng5.   

Abstract

To date, inadequate study has been devoted to the toxic vestibular effects caused by cisplatin. In addition, no electrophysiological examination has been conducted to assess cisplatin-induced otolith toxicity. The purposes of this study are thus two-fold: 1) to determine whether cervical vestibular-evoked myogenic potentials (VEMPs) and ocular VEMPs are practical electrophysiological methods of testing for cisplatin-induced otolith toxicity and 2) to examine if D-methionine (D-met) pre-injection would protect the otolith organs against cisplatin-induced changes in enzyme activities and/or oxidative status. Guinea pigs were intraperitoneally treated once daily with the following injections for seven consecutive days: sterile 0.9% saline control, cisplatin (5 mg/kg) only, D-met (300 mg/kg) only, or a combination of d-met (300 mg/kg) and cisplatin (5 mg/kg), respectively, with a 30 minute window in between. Each animal underwent the oVEMP and cVEMP tests before and after treatment. The changes in the biochemistry of the otolith organs, including membranous Na(+), K(+)-ATPase and Ca(2+)-ATPase, lipid peroxidation (LPO) levels and nitric oxide (NO) levels, were also evaluated. In the cisplatin-only treated guinea pigs, the mean amplitudes of the oVEMP tests were significantly (p<0.05) decreased when compared to the other three groups. In guinea pigs receiving both D-met and cisplatin, the amplitudes of their oVEMP tests were significantly larger (p<0.05) than those of the cisplatin-only group, but smaller (p<0.05) than those of the saline control or D-met-only group. However, no significant difference of the amplitudes of cVEMP tests was noted among the four groups. In comparison with the other three groups, the cisplatin-only group had the lowest (ps<0.05) mean Na(+), K(+)-ATPase and Ca(2+)-ATPase, and the highest (ps<0.05) LPO and NO levels. The oVEMP tests were feasible for the evaluation of cisplatin-related otolith dysfunction. D-Met attenuated the reduced ATPase activities and increased oxidative stress induced by cisplatin toxicity in the otolith organs.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone-conducted vibration; Lipid peroxidation; Nitric oxide; Vestibular-evoked myogenic potential; d-Methionine

Mesh:

Substances:

Year:  2015        PMID: 26219586     DOI: 10.1016/j.ntt.2015.07.004

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  6 in total

1.  Quantitative Assessment of Anti-Gravity Reflexes to Evaluate Vestibular Dysfunction in Rats.

Authors:  Vanessa Martins-Lopes; Anna Bellmunt; Erin A Greguske; Alberto F Maroto; Pere Boadas-Vaello; Jordi Llorens
Journal:  J Assoc Res Otolaryngol       Date:  2019-07-11

2.  Protective Effect of D-Methionine on Body Weight Loss, Anorexia, and Nephrotoxicity in Cisplatin-Induced Chronic Toxicity in Rats.

Authors:  Ming-Tai Lin; Jiunn-Liang Ko; Te-Chung Liu; Pei-Tsen Chao; Chu-Chyn Ou
Journal:  Integr Cancer Ther       Date:  2018-02-11       Impact factor: 3.279

Review 3.  Progress in the Development of Preventative Drugs for Cisplatin-Induced Hearing Loss.

Authors:  Robert A Hazlitt; Jaeki Min; Jian Zuo
Journal:  J Med Chem       Date:  2018-02-01       Impact factor: 7.446

4.  D-Methionine Ameliorates Cisplatin-Induced Muscle Atrophy via Inhibition of Muscle Degradation Pathway.

Authors:  Ching-Te Wu; Jiuan-Miaw Liao; Jiunn-Liang Ko; Yao-Ling Lee; Hui-Yi Chang; Cheng-Hsi Wu; Chu-Chyn Ou
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

5.  D-methionine alleviates cisplatin-induced mucositis by restoring the gut microbiota structure and improving intestinal inflammation.

Authors:  Cheng-Hsi Wu; Jiunn-Liang Ko; Jiuan-Miaw Liao; Shiang-Suo Huang; Meei-Yn Lin; Ling-Hui Lee; Li-Yu Chang; Chu-Chyn Ou
Journal:  Ther Adv Med Oncol       Date:  2019-02-12       Impact factor: 8.168

Review 6.  Preferential Cochleotoxicity of Cisplatin.

Authors:  Pattarawadee Prayuenyong; David M Baguley; Corné J Kros; Peter S Steyger
Journal:  Front Neurosci       Date:  2021-07-26       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.